thalidomide has been researched along with Brain Dead in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santana, AC | 2 |
| Andraus, W | 2 |
| Silva, FMO | 2 |
| Dellê, H | 2 |
| Pepineli, R | 2 |
| de Moraes, EL | 2 |
| Scavone, C | 1 |
| de Sá Lima, L | 1 |
| Degaspari, S | 1 |
| Brasil, S | 2 |
| Solla, DJF | 1 |
| Ruiz, LM | 2 |
| de Oliveira-Braga, KA | 2 |
| Nepomuceno, NA | 2 |
| Pêgo-Fernandes, PM | 2 |
| Tullius, SG | 1 |
| Figueiredo, EG | 2 |
| Sala, ACG | 1 |
| Schust, AS | 1 |
| Neri, LHM | 1 |
| Feliciano, R | 1 |
| Dos Santos, MJ | 1 |
2 other studies available for thalidomide and Brain Dead
| Article | Year |
|---|---|
Immunomodulatory effects of thalidomide in an experimental brain death liver donor model.
Topics: Allografts; Animals; Brain Death; Disease Models, Animal; Graft Rejection; Humans; Liver; Liver Tran | 2021 |
Thalidomide modulates renal inflammation induced by brain death experimental model.
Topics: Animals; Brain Death; Creatinine; Cytokines; Disease Models, Animal; Inflammation; Interleukin-6; Ma | 2022 |